Pennsylvania medical marijuana

Viewing posts tagged Pennsylvania medical marijuana

Week in Review: Pennsylvania flower sales, Oregon’s cannabis surplus & MassRoots’ big losses

Pennsylvania’s medical cannabis dispensaries get the OK to sell flower for vaping, Oregon’s marijuana glut is hurting the state’s smaller growers, and MassRoots reveals that its losses widened to $44 million in 2017.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

Positive in Pennsylvania

The announcement that Pennsylvania’s medical marijuana dispensaries can sell dry leaf and flower for vaping is good news for the industry’s bottom line, according to a Keystone State MMJ business owner who is trying to build her company.

Corinne Ogrodnik, the CEO and co-founder of Pittsburgh-based Maitri Medicinals, said the allowance of flower will bring more patients into the program and help grow a market that could become one of the nation’s largest.

“It will be a more affordable product because we won’t have to be utilizing the equipment to process the flower and leaf into concentrates,” she said. “It will also require less intensive packaging.”

Ogrodnik also is hopeful that being able to offer flower will help her business get off the ground.

The restraints on Pennsylvania’s MMJ business owners make it a capital-intensive process, including costs for:

  • Renovating properties
  • Security
  • Medical staff

“We were looking at a few years of lean times,” Ogrodnik said, “and (flower) is really going to enable us to fully implement our business plan with the anticipation of how the market is going to expand.”

Other medical marijuana markets that allow flower for vaping require the dry plant material to be offered in a prepackaged vaping device.

Ogrodnik said it’s unclear how Pennsylvania will regulate the sale and consumption of dry leaf and flower.

She hopes dispensaries will be able to sell whole flower, rather than prepackaged or preground plant matter, and patients are allowed to decide how they will vaporize it.

No matter how it plays out, Ogrodnik believes the program is moving in the right direction.

“It demonstrates that the Department of Health supports this program working, which then translates to the viability of our business,” she added.


Read the full article HERE.

Pennsylvania medical marijuana businesses may soon sell flower for vaping

Pennsylvania’s medical cannabis board has recommended allowing the sale of flower for vaping.

All that stands in the way of MMJ flower sales is a go-ahead from the state’s secretary of health, according to

Adding flower to the list of available products should boost the bottom line of Pennsylvania’s cannabis companies.

Flower is one of the most affordable and commonly purchased forms of cannabis.

Here’s what you need to know:

  • The board voted 11-0 to allow “dry leaf or plant form for administration by vaporization.” One member abstained.
  • Pennsylvania’s MMJ businesses currently can sell only oil, pills, tinctures or concentrate for vaping as well as ointments.
  • As of April 6, more than 25,000 MMJ patients were signed up to purchase medical cannabis, and 914 doctors were registered to recommend medical cannabis.
  • The advisory board is also expected to vote on whether to add terminal illness and palliative care to the list of medical conditions that can be treated with MMJ.

Read the full article HERE

Pennsylvania Green Lights Medical Cannabis Program Expansion

There have been issues with launching the medical cannabis program in the state of Pennsylvania, including dispensaries experiencing a shortage of available product for patients. Despite this, the State Department of Health recently announced it would be accepting more applications for new dispensaries and growing operations in April of this year.

According to NBC 10 Philadelphia, 13 permits will be up for grabs for growers and processors, while 23 will be available for dispensaries. In addition to the permits for dispensaries and grow-ops, the expansion of Pennsylvania’s medical marijuana program will include issuing permits to ‘clinical registrants’ for medical schools and hospitals who are interested in doing tests and much-needed research on the plant medicine.

One of those schools will likely be Thomas Jefferson University, who say they want to become an “academic clinical research center”. In 2017, Thomas Jefferson University received a donation of $3 million from Australian philanthropists Barry and Joy Lambert. The University used this donation to found the Lambert Center for the Study of Medical Cannabis and Hemp.

“This could really put Pennsylvania into the forefront of this whole controversial and challenging area,” Dr. Charles Pollack, director of the Lambert Center, told NBC10 after the university received the donation.

There are several other schools that are eager to run clinical tests on cannabis, including the University of Pittsburgh.

“We believe that the research will be of great importance in determining the safety and efficacy of medical cannabis products in treating specific diseases,” the University of Pittsburgh said in a statement.

Even though the Keystone State’s medical cannabis program is relatively restricted in comparison to that of other states, it is the only one that has introduced research elements. Ohio and Florida have both discussed research components in their programs, but there has not been any laws on the books as of yet.

Read the full article HERE.

How Jefferson Health birthed the nation’s first major marijuana research program

by Sam Wood

The medical marijuana program in Pennsylvania is about to enter unprecedented territory as it embarks on the nation’s first state-sanctioned research program.

 Medical schools will partner with marijuana companies. The med schools will design research studies. The companies, which will grow cannabis and sell it at their dispensaries, will enlist patients for the studies. The companies will collect patient data to be analyzed by the medical schools.

Unlike traditional drug studies, which provide experimental medicines at no cost, patients will buy the drug under investigation.

 “It’s not a normal pharmaceutical research structure by any means,” said Eric Hagarty, deputy chief of staff to Gov. Wolf. “The conflict with federal law is primarily the reason for that.”

The federal government considers all forms of marijuana to be illegal.

Backers say the program’s research arm is unique in the U.S. and could make the state a global hub for cannabis science. Philadelphia may host up to five academic centers investigating applications for the drug.

Enabling this to happen is a provision of the marijuana law many call the “Jefferson Amendment.”

Nicknamed after Philadelphia’s Jefferson Health system, which was instrumental in the law’s creation, the Jefferson Amendment is officially known as Chapter 20 of the state’s medical marijuana act. It allows as many as eight health systems to each pair with a private company. A health system, under the law, is defined as a medical school with an acute-care hospital.

 In language only a bureaucrat could love, the law calls the medical schools “Academic Clinical Research Centers” (ACRCs) and deems the marijuana companies “Clinical Registrants” (CRs).

“The whole goal is to bring research and sophistication to cannabis that doesn’t exist in the rest of the state or the country,” said James Connolly, a former vice president at drug maker Wyeth. Connolly will head Solterra Care, LLC, the CR affiliated with Jefferson. “It will put us on the map if Philadelphia has three, four or five research centers and brings some credibility to the industry.”

Drexel, Temple, and the University of Pennsylvania are each expected to participate as research centers. Philadelphia College of Osteopathic Medicine is also angling to get in, though the school lacks a hospital on campus.

The state Department of Health will begin accepting applications on April 5.



Read the full article HERE

Philadelphia mall fight could affect state marijuana laws

A fight over a Philadelphia mall’s deed restrictions belongs in federal court because it could end up affecting the legality of medical marijuana dispensaries in the state, a federal judge ruled Wednesday.

PharmaCann Penn LLC is challenging a deed restriction that prevents it from using the mall space it bought for any “activity or use which is unlawful.” The company has a state license and city zoning approval to operate a dispensary.

Simon Property Group Inc., the mall owner, contends the deed restriction prevents PharmaCann from opening the dispensary because dispensing marijuana is a federal crime.


Read the full article HERE


Hill doctor opens medicinal marijuana prescription practice

by Elizabeth Coady

Tucked in the rear first floor of 7811 Germantown Ave. is Dr. Rebecca Maury’s newly founded medical marijuana practice, Herbal Wellness Rx.

Maury, a Chestnut Hill resident who is board-certified in internal medicine and hospice and palliative care, this week quietly begins treating patients seeking to alleviate suffering from 17 serious medical conditions for which the state of Pennsylvania allows medicinal marijuana to be used.

Maury is among 433 physicians who have completed four hours of state-mandated training and are certified to treat patients seeking medical marijuana. Pennsylvania is one of 30 states that have legalized the use of the medicinal plant, still classified as an illegal drug by federal authorities, according to The Keystone state’s Medical Marijuana Program was approved by legislators in April 2016 and went live Feb. 15 when the first dispensaries opened.

“It’s still something that’s coming out of the shadows,” Maury said. “But it’s something I believe in. I feel happy to be part of the movement to get it out in the mainstream.”

The Washington, D.C., native has been ahead of the curve on using herbs to heal for decades. Even before enrolling in medical school, she attended the New Mexico School for Natural Therapeutics, a massage therapy and holistic wellness program, and the Southwest School for Botanical Medicine, where she studied the healing benefits of herbs.

According to her biography at, Maury then “spent several years traveling through the Southwest, wildcrafting herbs and studying their properties.”

She subsequently graduated summa cum laude from the University of New Mexico with a bachelor’s in biology and then attended the university’s medical school. She found her way to Philadelphia via her internist’s residency at Thomas Jefferson University Hospital.

At Jefferson, she gravitated toward hospice and palliative care and discovered her ease in comforting patients with life-threatening and end-of-life illnesses.

“I was always interested in the healing arts,” Maury said, recalling how she would take care of baby squirrels that fell out of trees. “I sort of always have wanted to take care of beings. That’s just part of my nature.”

That innate caring proved a gift when dealing with the sick and dying, which she says “has the potential to be a beautiful, natural transformation.”

Treating patients with medical marijuana is a natural evolution in her caring for the sick. As she witnessed Pennsylvania’s slow roll toward legalization over the last several years, she thought to herself, “Gosh, this is something I should be making available to people. It’s a natural remedy. It has a very low if any possibility for complications for addiction.”

She points out the plant was used for centuries as a medicinal herb before being stigmatized in the early 20th century, in part by the medical industry. Even now the drug is viewed with disdain or stigma among some members of society.

But increasingly, the evidence for the health benefits of marijuana is winning out over old biases. Today, marijuana is used to ameliorate glaucoma and epilepsy, alleviate nausea and boost appetite in cancer and AIDS patients, ease post-traumatic stress disorder, lessen neuropathy from chemotherapy’s side effects, aide in sleep disorders and improve spasticity in Parkinson’s and multiple sclerosis sufferers, to name a few ways it’s currently used.

Cannabinoids, a chemical component of pot, also has an “amazing anti-inflammatory component,” Maury said.

Under the new state laws, physicians who treat patients will review their medical histories and issue a letter certifying they are eligible to use medical marijuana. The patient, who must already be enrolled and issued an ID to participate in the state’s program, then takes the physician’s letter to the dispensary where they consult with a pharmacist or nurse practitioner on the optimal form, strain and TCH concentration of their marijuana treatment. Patients must pay out-of-pocket for their treatments.

Pennsylvania’s law allows for medical marijuana to be sold in liquid, pill, tincture, oil, and topical forms but forbids the sale of leaf, although members of the state’s Medical Marijuana Advisory Board are currently considering including the sale of dried leaves to patients.

So far, 21,000 patients have registered to participate in the state’s medical marijuana program and 6,000 of those have been approved as eligible to participate by a physician, according to April Hutcheson, of the Pennsylvania Department of Health.

Pennsylvania has had the fastest rollout among state medical marijuana programs, according to Christine Visco, co-owner of TerraVida Holistic Center, one of the state’s 50 licensed dispensaries. Each licensed dispensary is allowed to operate in three locations in separate counties. TerraVida is licensed to operate dispensaries in Sellersville, Abington and Malvern.


Read the full article HERE

City Council Committee Reveals Employment Risks For Medical Marijuana Users

By Pat Loeb


PHILADELPHIA (CBS) — Pennsylvania has made medical marijuana legal, but it can’t completely shield people who take it from consequences. A city council committee hearing last week highlighted potential problems for patients.

Pennsylvania law says a person can’t lose their job because they’re certified to use medical marijuana, but attorney George Voegele told the panel it also doesn’t require an employer to accommodate marijuana use.

“Zero tolerance policies are still okay,” Voegele said. “You can discipline or terminate an employee for failing a drug test and, of course, you can still discipline an employee who’s under the influence.”

Veogele says that may change if challenged in court, but some jobs, such as truck drivers, regulated by federal law, would still not be protected and the state sets aside a number of jobs users can’t do.

“No one wants someone using medical marijuana driving their children’s school bus,” he said, “or up in a cherry picker working on power lines.”

Councilwoman Cherelle Parker was distressed to learn of the employment risks.

“The notion that someone suffering from PTSD or cancer could lose their job because they are a medical marijuana patient was devastating,” Parker said.

She hopes for a public awareness campaign for employers and workers.


Read the full article HERE

Philadelphia Medical Marijuana Case Could Have Nationwide Impact

By Pat Loeb

PHILADELPHIA (CBS) — A federal judge in Philadelphia is considering whether to take a case that could have an enormous impact on the medical marijuana industry nationwide.

The case involves a dispensary permitted for Philadelphia Mills in the Northeast.

Pharma Cann got a state permit and city approval to open in a former Chi-Chi’s near the Mall, but mall operator, Simon Property, sued in federal court to block it from opening.

It claims the deed forbids “illegal activity” and that would include the dispensary since marijuana is illegal under federal law.

Pharma Cann wants the issue resolved in Common Pleas Court, arguing it’s simply a case of an outdated restrictive covenant. Its attorney, Jeremy Unruh, says Simon’s attempt to make it a federal case is unduly excessive.

“I think they’re trying to mushroom this into the bigger policy issue as to whether or not the federal controlled substances act operates to preclude all 30 of the states that now have some sort of state medical marijuana law on their books,” he said.

Simon’s attornies declined to comment.

Judge Gene Pratter has heard oral arguments and given the two sides until this week for written comments before she rules on whether she’ll keep the case in federal court and hear those bigger policy issues.


Read the full article HERE

PA medical cannabis shops low on product; state OKs more licenses

Pennsylvania’s medical marijuana dispensary owners are experiencing a common occurrence among new markets: a supply shortage.

Only two weeks after the state launched sales, some dispensaries have run out of product because of limited supply and unexpected demand, the Philadelphia Inquirer reported.

That news coincides with an announcement that the state has approved two more dispensaries to open their doors.

Here’s what you need to know:

  • Because of supply issues, TerraVida Holistic Center is operating on modified hours and the Keystone Shop was forced to close. Both are in the Philadelphia area.
  • Roughly 21,000 people have begun the process to receive their medical marijuana cards, and more than 2,000 have purchased medical marijuana from a dispensary.
  • Only one producer, Cresco Yeltrah, is currently providing MMJ products to six open dispensaries.
  • Other states, including Maryland and Hawaii, have gone through similar supply problems in the early days of sales.
  • In addition to the two dispensaries, Pennsylvania regulators have approved a grower-processor to start operations, bringing the total of approved growers to 12, according to


Read the full article HERE